A brief history of antidepressant drug development: from tricyclics to beyond ketamine
出版年份 2018 全文链接
标题
A brief history of antidepressant drug development: from tricyclics to beyond ketamine
作者
关键词
-
出版物
ACTA NEUROPSYCHIATRICA
Volume -, Issue -, Pages 1-16
出版商
Cambridge University Press (CUP)
发表日期
2018-02-01
DOI
10.1017/neu.2017.39
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Considerations on the Off-label Use of Ketamine as a Treatment for Mood Disorders
- (2017) Samuel T. Wilkinson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders
- (2017) C A Zarate et al. MOLECULAR PSYCHIATRY
- New targets for rapid antidepressant action
- (2017) Rodrigo Machado-Vieira et al. PROGRESS IN NEUROBIOLOGY
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
- (2017) Gerard Sanacora et al. JAMA Psychiatry
- GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice
- (2016) Lakshmi Rajagopal et al. BEHAVIOURAL BRAIN RESEARCH
- KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS
- (2016) Chadi G. Abdallah et al. DEPRESSION AND ANXIETY
- Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice
- (2016) Ewa Poleszak et al. METABOLIC BRAIN DISEASE
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders
- (2016) G Sanacora et al. NEUROPSYCHOPHARMACOLOGY
- Antidepressant drug action — From rapid changes on network function to network rewiring
- (2016) Tomi Rantamäki et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review
- (2016) Kristian Gaarn du Jardin et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
- (2015) Chadi G. Abdallah et al. Annual Review of Medicine
- NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism
- (2015) Carly Kiselycznyk et al. BEHAVIOURAL BRAIN RESEARCH
- Atypical Neurotransmitters and the Neurobiology of Depression
- (2015) Samia Joca et al. CNS & Neurological Disorders-Drug Targets
- Recent insights into the mode of action of memantine and ketamine
- (2015) Jon W Johnson et al. CURRENT OPINION IN PHARMACOLOGY
- Randomized Proof of Concept Trial of GLYX-13, an N-Methyl-D-Aspartate Receptor Glycine Site Partial Agonist, in Major Depressive Disorder Nonresponsive to a Previous Antidepressant Agent
- (2015) SHELDON PRESKORN et al. Journal of Psychiatric Practice
- Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor
- (2015) Kinga Sałat et al. NEUROPHARMACOLOGY
- Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains
- (2015) Michael R Weed et al. NEUROPSYCHOPHARMACOLOGY
- The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus
- (2015) J. Burgdorf et al. NEUROSCIENCE
- Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
- (2015) Eleonore Beurel et al. PHARMACOLOGY & THERAPEUTICS
- Ketamine and other potential glutamate antidepressants
- (2015) Arpan Dutta et al. PSYCHIATRY RESEARCH
- Antidepressant-like effects induced by NMDA receptor blockade and NO synthesis inhibition in the ventral medial prefrontal cortex of rats exposed to the forced swim test
- (2015) Vitor Silva Pereira et al. PSYCHOPHARMACOLOGY
- Nitric oxide involvement in the antidepressant-like effect of ketamine in the Flinders sensitive line rat model of depression
- (2014) Nico Liebenberg et al. ACTA NEUROPSYCHIATRICA
- Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?
- (2014) Gerard Sanacora et al. NEUROPSYCHOPHARMACOLOGY
- New paradigms for treatment-resistant depression
- (2013) Carlos Zarate et al. Annals of the New York Academy of Sciences
- Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
- (2013) John H. Krystal et al. BIOLOGICAL PSYCHIATRY
- Ketamine in Pain Management
- (2013) Jan Persson CNS Neuroscience & Therapeutics
- From “Special K” to “Special M”: The Evolution of the Recreational Use of Ketamine and Methoxetamine
- (2013) Ornella Corazza et al. CNS Neuroscience & Therapeutics
- Tropisetron attenuates amyloid-beta-induced inflammatory and apoptotic responses in rats
- (2013) Reza Rahimian et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Antidepressant- and anticompulsive-like effects of purinergic receptor blockade: Involvement of nitric oxide
- (2013) Vitor S. Pereira et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- mTOR complexes in neurodevelopmental and neuropsychiatric disorders
- (2013) Mauro Costa-Mattioli et al. NATURE NEUROSCIENCE
- NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
- (2013) Pierre Paoletti et al. NATURE REVIEWS NEUROSCIENCE
- GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects
- (2013) Jeffrey Burgdorf et al. NEUROPSYCHOPHARMACOLOGY
- GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine
- (2013) Rong-Jian Liu et al. NEUROPSYCHOPHARMACOLOGY
- Inhibition of the l-arginine–nitric oxide pathway mediates the antidepressant effects of ketamine in rats in the forced swimming test
- (2013) Guang-Fen Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice
- (2013) Xian-Cang Ma et al. PLoS One
- Pharmacological blockade of GluN2B-containing NMDA receptors induces antidepressant-like effects lacking psychotomimetic action and neurotoxicity in the perinatal and adult rodent brain
- (2013) Juan M. Lima-Ojeda et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Maximum Tolerated Dose Evaluation of the AMPA Modulator Org 26576 in Healthy Volunteers and Depressed Patients
- (2013) Kari R. Nations et al. Drugs in research & development
- Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression
- (2012) Xiaochen Zhao et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
- (2012) Lobna Ibrahim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial
- (2012) Kari R Nations et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
- (2011) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex
- (2011) Rong-Jian Liu et al. BIOLOGICAL PSYCHIATRY
- Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
- (2011) E Beurel et al. MOLECULAR PSYCHIATRY
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Potential therapeutic uses of BDNF in neurological and psychiatric disorders
- (2011) Alan H. Nagahara et al. NATURE REVIEWS DRUG DISCOVERY
- Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels
- (2011) Alessandro Barbon et al. NEUROCHEMISTRY INTERNATIONAL
- The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf+/− heterozygous null mice
- (2011) Jesse S.O. Lindholm et al. NEUROPHARMACOLOGY
- Towards a glutamate hypothesis of depression
- (2011) Gerard Sanacora et al. NEUROPHARMACOLOGY
- Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm
- (2010) Severine Farley et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Chronic ketamine use increases serum levels of brain-derived neurotrophic factor
- (2010) Valerio Ricci et al. PSYCHOPHARMACOLOGY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today
- (2009) Francisco Lopez-Munoz et al. CURRENT PHARMACEUTICAL DESIGN
- CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls
- (2009) Francisco A. Moreno et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Half a Century of Antidepressant Drugs
- (2009) Peter Fangmann et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Positive AMPA Receptor Modulation Rapidly Stimulates BDNF Release and Increases Dendritic mRNA Translation
- (2009) H. Jourdi et al. JOURNAL OF NEUROSCIENCE
- The N-methyl-d-aspartate receptor modulator GLYX-13 enhances learning and memory, in young adult and learning impaired aging rats
- (2009) Jeffrey Burgdorf et al. NEUROBIOLOGY OF AGING
- Glutamate-based antidepressants: 20 years on
- (2009) Phil Skolnick et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
- (2008) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The effect of MK-801 on mTOR/p70S6K and translation-related proteins in rat frontal cortex
- (2008) Se Chang Yoon et al. NEUROSCIENCE LETTERS
- Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice
- (2008) Oguz Mutlu et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
- Do ATP and NO interact in the CNS?
- (2007) F. Florenzano et al. PROGRESS IN NEUROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now